Manieu Alexandre Weinstein reported grant involving 180,000 shares of Pluri Inc. at $0.00 for $0 on Aug 20, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Aug 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
180,000Common Shares
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
190,769Direct
Trade date
Aug 20, 2026Grant
Filed
Aug 24, 2026, 4:29 PM ET4-day reporting delay
Accession
0001213900-26-093064Code A · Transaction 83725
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PLUR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PLUR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +25%1w ago +6.4%1d ago +13%
Returns since7d −5.8%30d −29%90d180d1y

Footnotes in full

F1: Consists of common shares underlying restricted stock units ("RSUs") that were granted by the Board of Directors on August 20, 2026. The RSUs vest over three years as follows: 50% of RSUs will vest on a quarterly basis during the first year following the date of grant, 25% will vest on a quarterly basis during the second year following the date of grant and the remaining 25% will vest on a quarterly basis during the third year following the date of grant. F2: Includes 10,769 RSUs under two separate equity plan agreements, as previously reported. F3: Mr. Weinstein owns 100% of Chutzpah Holdings LP ("CHLP") and may be deemed to beneficially own securities owned by CHLP. CHLP is the 100% owner of Chutzpah Holdings Limited ("CHL"). CHL owns approximately 78% of Plantae Bioscience Ltd. ("Plantae"), and Mr. Weinstein may be deemed to indirectly beneficially own securities owned by both Plantae and CHL through his 100% indirect ownership of CHLP. F4: (Continuation of Footnote (3)) Mr. Weinstein expressly disclaims beneficial ownership with respect to any common shares of the Issuer, except to the extent of his pecuniary interest in such securities. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.